Finance

Beta
Lists
PRCT:NASDAQ
Procept Biorobotics Corp
$28.35
+1.87%
(+0.52) 1D
$28.26
-0.32% (-0.090)
After hours
Closed: Jun 8, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PRCT...
Open
$27.73
High
$29.41
Low
$27.72
Mkt. cap
1.61B
Avg. vol.
1.50M
Volume
1.31M
52-wk high
$64.89
52-wk low
$19.35
EPS
-$1.83
Beta
0.85
Shares outstanding
56.92M
No. of employees
888
Open
$27.73
High
$29.41
Low
$27.72
Mkt. cap
1.61B
Avg. vol.
1.50M
Volume
1.31M
52-wk high
$64.89
52-wk low
$19.35
EPS
-$1.83
Beta
0.85
Shares outstanding
56.92M
No. of employees
888
Analyst outlook
Analyst Ratings
Based on 9 analysts giving stock ratings to PRCT in the past 3 months
Buy
Buy
6
Hold
2
Sell
1
12 month forecast
Based on 9 Wall Street analysts offering 12 month price targets for PRCT in the last 3 months.
Highest
Current $28.35
$51.00 (+79.89%)
Average
$33.67 (+18.77%)
Lowest
$20.00 (-29.45%)
News stories
From sources across the web
About Procept Biorobotics Corp
CEO-
Employees888
Founded2007
HeadquartersSan Jose, California, United States
SectorMedical device
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
79.18M
83.33M
76.38M
83.13M
Cost of goods sold
27.44M
29.32M
30.07M
29.18M
Cost of revenue
27.44M
29.32M
30.07M
29.18M
Research and development expenses
17.63M
18.19M
19.06M
21.46M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
56.30M
59.01M
58.30M
65.09M
Operating expense
73.94M
77.20M
77.35M
86.55M
Total operating expenses
101.37M
106.52M
107.42M
115.74M
Operating income
-22.19M
-23.19M
-31.04M
-32.61M
Other non operating income
-
-
-156.00K
-
EBT including unusual items
-19.58M
-21.41M
-29.66M
-31.68M
EBT excluding unusual items
-19.58M
-21.41M
-29.66M
-31.68M
Income tax expense
-
-
190.00K
-43.00K
Effective tax rate
-
-
-0.64%
0.14%
Other operating expenses
-
-
-
-
Net income
-19.58M
-21.41M
-29.84M
-31.64M
Net profit margin
-24.73%
-25.70%
-39.07%
-38.06%
Earnings per share
-0.35
-0.38
-0.53
-0.56
Interest and investment income
3.51M
2.70M
2.44M
1.74M
Interest expense
-895.00K
-919.00K
-894.00K
-818.00K
Net interest expenses
2.61M
1.78M
1.54M
925.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-20.60M
-21.57M
-29.33M
-30.87M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more